Today: October 5, 2015, 1:45 am

Myanmar pharmaceuticals market: $320mn industry in 2013
Myanmar Pharmaceuticals and Healthcare Report Q3 2013 - a new market research report on 2014-04-24 09:47:03
Despite its small size, Myanmar´s pharmaceutical market offers drugmakers strong revenueearning opportunities. Generic and over-the-counter drug companies in particular stand to benefit, as the population´s per capita expenditure on pharmaceuticals and healthcare remains low but set to rise.

However we believe that the country remains a high-risk market as a result of political risks arising from ethnic tensions, in addition to the challenging economic framework - the result of corruption and unclear regulations.

Headline Expenditure Projections

oPharmaceuticals: MMK241.2bn (US$280mn) in 2012 to MMK279.5bn (US$320mn) in 2013; +15.9% in local currency terms and 14.1% in US dollar terms.

oHealthcare: MMK992.5bn (US$1.1bn) in 2012 to MMK1,098.4bn (US$1.3bn) in 2013; +10.7% in local currency terms and +9.0% in US dollar terms.

Click for report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Press Information

Published by
Mike King
London: +44 (0) 203 086 8600

# 329 Words
Related Articles

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.